http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2566445-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f38f84a08fb4b22c63d460911988d1c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-34
filingDate 2013-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a560c3d94a97e18591f0b7e2827466eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94e02a33d8e0827d3d661630c5137c2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7eee6e6117615f5d3606c9301523f811
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f592344a07e51d36c7c783491b8ab40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb193276780793706165a85786593a69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b0bcf3582fd815617dd3dca8b518459
publicationDate 2015-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2566445-C2
titleOfInvention 5-oxypyrimidine derivatives possessing immunomodulatory activity
abstract FIELD: chemistry. n SUBSTANCE: invention refers to new 2-isopentyl-4,6-dimethyl-5-oxypyrimidine of formula (I) possessing immunomodulatory activity. The compounds can be used in medicine as an immunomodulatory agent for producing preparations used in treating immunodeficient diseases, infectious diseases, after radiation therapy, in various age-related and functional immune response failures. The compound of formula (I) in stimulating the cell immunity causes the pronounced stimulation of various T-lymphocyte subpopulations when administered in the wide range of doses. (I) , wherein R is isopentyl. A method for producing the compound of formula (I) consists in a reaction of isocapronic acid amide in glacial acetic acid with chloroacetyl acetone to produce 2-isopentyl-4-methyl-5-acetyloxazole, which reacts to ammonia solution to produce a target compound. n EFFECT: compound is low-toxic, has the sufficiently pronounced antioxidant properties having the anti-inflammatory action and improving the body resistance to infections. n 3 cl, 4 tbl, 3 ex
priorityDate 2013-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008221103-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1499883-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420173279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429473992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451203358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415767435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420554478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID290807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID142765521
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14496856
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID142766376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453327643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429465262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393673
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID565855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409783617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413806416

Total number of triples: 43.